Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

Go back to Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
(NASDAQ: ENSC) Delayed: 0.46 +0.01 (2.22%)
Previous Close $0.45    52 Week High
Open $0.45    52 Week Low
Day High $0.46    P/E N/A 
Day Low $0.44    EPS
Volume 495,829